Reagents and instruments for immunology, cell biology and molecular biology.
 
> Adrenocorticotropic Hormone (ACTH) (4-10) TFA

Adrenocorticotropic Hormone (ACTH) (4-10) TFA

Print Print
Please log in

Cat# T7627L-5mg

Size : 5mg

Brand : TargetMol

Contact local distributor :


Phone : +1 850 650 7790

Adrenocorticotropic Hormone (ACTH) (4-10) TFA

(Synonyms: Adrenocorticotropic Hormone (ACTH) (4-10) TFA(4037-01-8(free base)), Acth (4-10)) Copy Product Info
Adrenocorticotropic Hormone (ACTH) (4-10) TFA (Acth (4-10)) is an agonist of potent melanocortin(MC4R) receptor .
Adrenocorticotropic Hormone (ACTH) (4-10) TFA
Other Forms of Adrenocorticotropic Hormone (ACTH) (4-10) TFA:
ACTH (1-17) acetate
ACTH (1-17) (TFA) (7266-47-9 free base)
ACTH (4-11)
ACTH (1-13)
Acth (1-4) acetate(19405-50-6 free base)
Acth (1-4)
ACTH (1-14)
ACTH (1-14) TFA (25696-21-3 free base)
ACTH (34-39)
ACTH (11-24)
Adrenocorticotropic Hormone (ACTH) (4-10), human
Adrenocorticotropic Hormone (ACTH) (1-39), rat TFA
ACTH (22-39) acetate
Adrenocorticotropic Hormone (ACTH) (1-39), rat
ACTH (1-17)
ACTH (22-39)
For research use only—not for human use. No sales to individuals. Use as intended only.

Batch Information

Select Batch
Purity:98.49%
Appearance:Solid
Color:White

Resource Download

COA LCMS HNMR

Product Introduction

Bioactivity
Description
Adrenocorticotropic Hormone (ACTH) (4-10) TFA (Acth (4-10)) is an agonist of potent melanocortin(MC4R) receptor .
In vivo
In humans, Adrenocorticotropic Hormone (ACTH) (4-10)?enters the cerebral fluid compartment after intranasal application and leads to a?decrease in total body fat after 6 weeks of continuous treatment[1].
SynonymsAdrenocorticotropic Hormone (ACTH) (4-10) TFA(4037-01-8(free base)), Acth (4-10)
Chemical Properties
Molecular Weight1076.12
FormulaC46H60F3N13O12S
SmilesOC(=O)C(F)(F)F.CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(O)=O
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 250 mg/mL (232.32 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Saline: 10 mg/mL (9.29 mM), Solution.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM0.9293 mL4.6463 mL9.2926 mL46.4632 mL
5 mM0.1859 mL0.9293 mL1.8585 mL9.2926 mL
10 mM0.0929 mL0.4646 mL0.9293 mL4.6463 mL
20 mM0.0465 mL0.2323 mL0.4646 mL2.3232 mL
50 mM0.0186 mL0.0929 mL0.1859 mL0.9293 mL
100 mM0.0093 mL0.0465 mL0.0929 mL0.4646 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.